Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts

Molecular and Cellular Biochemistry

Volumn 157, Issue 1-2, 1996, Pages 171-179

  Bartel, Sabine ^a   Stein, Birgitt ^b   Eschenhagen, Thomas ^b   Mende, Ulrike ^b   Neumann, Joachim ^c   Schmitz, Wilhelm ^c   Krause, Ernst Georg ^a   Karczewski, Peter ^a   Scholz, Hasso ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Force of contraction; Human heart; Phospholamban; Protein phosphorylation

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; CYCLIC AMP; ISOPRENALINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHOLAMBAN; PHOSPHOPROTEIN; PIMOBENDAN; PROTEIN C; TROPONIN I;

ADULT; ARTICLE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE; HUMAN; HUMAN TISSUE; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TWITCH; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM;

EID: 0029968801     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00227896     Document Type: Article

References (37)

1. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sagemann WS, Luriek K, Billingham ME, Harrison DC, Stinson EB: Decreased catecholamine sensitivity and β-adrenergic receptor density in failing hearts. N Engl J Med 307: 205-211, 1982
2. Brown L, Lorenz B, Erdmann E: Reduced positive inotropic effects in diseased human ventricularmyocardium. Cardiovasc Res 20: 516-520, 1986
3. Schmitz W, Scholz H, Erdmann E: Effect of α- and β-adrenergic agonists, phosphodiesterase inhibitors and adenosine on isolated human muscle preparations. Trend Pharmacol Sci 8: 447-450, 1987
4. Feldman MD, Capelas L, Gwathmey JK: Deficient production of cyclic AMP: pharmacological evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75: 331-339, 1987
5. Danielsen W, Leyen H, Meyer W, Neumann J, Schmitz W, Scholz H, Starbatty J, Stein B, Doring V, Kalmar P: Basal and isoproterenol-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol 14: 171-173, 1989
6. von der Leyen H, Neumann J, Nose M, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff H, Doring V, Kalmar P, Haverich A: Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. Naunyn Schmiedeberg's Arch Pharmacol 344: 90-100, 1991
7. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP: Abnormal intracellular calcium handling in myocardium from patients with end-stage failure. Circ Res 61: 70-76, 1987
8. Packer M: Abnormalities of diastolic function as a pontential cause of exercise intolerance in chronic heart failure. Circulation 81 (Suppl III): 78-86, 1990
9. i-proteins in heart failure. Lancet II: 936-937, 1989
10. Feldman AM, Cates AE, Bristow MR, van Dop C: Altered expression of α-subunit of G proteins in failing human hearts. J Mol Cell Cardiol 21: 359-365, 1989
11. Murphree SS, Jeffrey E, Saffitz MD: Distribution of β-adrenergic receptors in failing human myocardium. Implications for mechanisms of down-regulation. Circulation 79: 1214-1225, 1989
12. Solaro RJ, Robertson SP, Johnson JD, Holroyde MJ, Potter JD: Troponin-I phosphorylation: A unique regulator of the amounts of calcium required to activate cardiac myofibrils. Cold Spring Harb Conf Cell Prolif 8: 901-911, 1981
13. Tada M, Katz AM: Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol 44: 401-423, 1982
14. England PJ: Phosphorylation of cardiac muscle contractile proteins. In: A.J. Drake-Holland and M.I.M Noble (eds). Cardiac Metabolism. John Wiley & Sons, New York, 1983, pp 365-389, 1983
15. Solaro RJ: Modulation of activation of cardiac myofilaments by beta-adrenergic agonists. In: J.A. Lee, D.G. Allen (eds). Modulation of Cardiac Calcium. Oxford University Press, 1993, pp 160-177
16. Beuckelmann DJ, Nabauer M, Erdmann E: Intracellular calcium handling in isolated venticular myocytes from patients with terminal heart failure. Circulation 85: 1045-10559, 1992
17. Zhang R, Zhao J, Mandveno A, Potter J D: Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 76: 1028-1035, 1995
18. Karozewski P, Bartel S, Krause EG: Differential sensitivity to isoproterenol of phospholamban and troponin I phosphorlyation in isolated rat hearts. Biochem J 266: 115-122, 1990
19. Scheffold T, Rempis A, Zehelein J, Franz W, Gruning E, Vosberg HP, Barton B, Katus A: Characterisation of the isoprotein composition of the myofilaments of human myocardium. Eur Heart J 14: Suppl 140 (Abstract), 1993
20. Laemmli UK: Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227: 680-685, 1970
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 265-275, 1951
22. Haase H, Karczewski P, Beckert R, Krause EG: Phosphorylation of the L-type calcium channel β-subunit is involved in β-adrenergic signal transduction in canine myocardium. FEBS lett 335: 217-222, 1993
23. Chen TC, Law B, Kondratyuk T, Rossie S: Identification of soluble protein phosphatases that dephosphorylate voltage-sensitive sodium channels in rat brain. J Biol Chem 270(13): 7750-7756, 1995
24. Towbin H, Staehelin T, Gordon I: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76: 4350-4354, 1979
25. Ungerer M, Parruti G, Böhm M, Puzicha M, Beblasi A, Erdmann E, Lohse MJ: Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circ Res 74: 206-213, 1994
26. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657, 1994
27. 2+-ATPase-activity of cardiac sarcoplasmic reticulum from patients with dilated cardiomyopathy compared to nonfailing patients. Circulation 92: 3220-3228, 1995
28. Hasenfuss G, Meyer M, Schillinger W, Pieske B, Scheffler A, Holubarsch C, Reinecke H: Expression of sarcoplasmic reticulum proteins in failing and nonfailing human myocardium. Circulation 90: 1160, 1994
29. 2+ ATPase and phospholamban proteins. Circulation 90: 1161, 1994
30. Sasse S, Brand NJ, Kyprianou P, Dhoot GK, Wade R, Arai M, Periasamy M, Yacoub MH, Barton PJR: Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res 72: 932-938, 1993
31. Morano I, Hadicke K, Grom S, Koch A, Schwinger RHG, Bohm M, Bartel S, Erdmann E, Krause EG: Titin, myosin light chains and C-protein in developing and failing human heart. J Mol Cell Cardiol 26: 361-368, 1994
32. Bohm M, Reiger B, Schwinger RHG, Erdmann E: cAMP concentrations, cAMP-dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 28: 1713-1719, 1994
33. 2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J Clin Invest 85: 1698-1702, 1990
34. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG: Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75: 401-409, 1994
35. 2+-sensitive tension due to partial extraction of C-protein from rat skinned cardiac myocytes and rabbit skeletal muscle fibers. J Gen Physiol 97: 1141-1163, 1991
36. Palmer CJ, Scott BT, Jones LR: Purification and complete sequence determination of the major plasma membrane substrate for cAMP-dependent protein kinase and protein kinase C in myocardium. J Biol Chem 266: 11126-11130, 1991
37. Yoshida A, Takahasi M, Imagawa T, Shigekawa M, Takisawa H, Nakamura T: Phosphorylation of ryanodine receptors in rat myocytes during beta-adrenergic stimulation J Biochem (Tokyo) 111: 186-190, 1992